| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| uniQure N.V. | Director | Ordinary Shares | 29,937 | $432,589 | $14.45 | 20 Jun 2025 | Direct |
| Fulgent Genetics, Inc. | Director | Common Stock | 8,000 | $213,516 | $26.69 | 01 Aug 2022 | Direct |
| CG Oncology, Inc. | Director | Common Stock | 0 | $0 | $41.43 | 17 Nov 2025 | Direct |
| CG Oncology, Inc. | Director | Stock Option | 133,077 | 16 Dec 2024 | Direct | ||
| CG Oncology, Inc. | Director | Director Stock Option (right to buy) | 117,077 | 17 Nov 2025 | Direct | ||
| uniQure N.V. | Director | Stock Option (Right to Buy) | 15,630 | 11 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 17 Nov 2025 | 3 | -$40,830 | 4 | Director | 18 Nov 2025, 16:30 |
| CGON | CG Oncology, Inc. | 13 Oct 2025 | 3 | -$42,650 | 4 | Director | 15 Oct 2025, 16:15 |
| CGON | CG Oncology, Inc. | 30 Sep 2025 | 3 | -$197,450 | 4 | Director | 01 Oct 2025, 17:07 |
| CGON | CG Oncology, Inc. | 15 Sep 2025 | 3 | -$34,500 | 4 | Director | 16 Sep 2025, 16:15 |
| CGON | CG Oncology, Inc. | 03 Sep 2025 | 3 | -$27,400 | 4 | Director | 04 Sep 2025, 16:30 |
| CGON | CG Oncology, Inc. | 17 Jul 2025 | 3 | -$54,800 | 4 | Director | 18 Jul 2025, 16:30 |
| QURE | uniQure N.V. | 20 Jun 2025 | 1 | -$30,518 | 4 | Director | 24 Jun 2025, 18:03 |
| QURE | uniQure N.V. | 11 Jun 2025 | 2 | $0 | 4 | Director | 13 Jun 2025, 17:07 |
| CGON | CG Oncology, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:00 |
| CGON | CG Oncology, Inc. | 21 May 2025 | 3 | -$27,400 | 4 | Director | 22 May 2025, 16:15 |
| CGON | CG Oncology, Inc. | 28 Apr 2025 | 3 | -$30,160 | 4 | Director | 29 Apr 2025, 16:15 |
| CGON | CG Oncology, Inc. | 17 Mar 2025 | 3 | -$27,400 | 4 | Director | 18 Mar 2025, 16:30 |
| CGON | CG Oncology, Inc. | 18 Feb 2025 | 3 | -$28,010 | 4 | Director | 19 Feb 2025, 16:15 |
| CGON | CG Oncology, Inc. | 13 Jan 2025 | 3 | -$29,060 | 4 | Director | 14 Jan 2025, 16:16 |
| CGON | CG Oncology, Inc. | 16 Dec 2024 | 3 | -$28,240 | 4 | Director | 17 Dec 2024, 17:00 |
| CGON | CG Oncology, Inc. | 06 Dec 2024 | 4 | -$33,942 | 4 | Director | 06 Dec 2024, 18:51 |
| CGON | CG Oncology, Inc. | 04 Oct 2024 | 1 | $0 | 4 | Director | 07 Oct 2024, 17:17 |
| QURE | uniQure N.V. | 19 Jun 2024 | 2 | $0 | 4 | Director | 21 Jun 2024, 17:00 |
| QURE | uniQure N.V. | 13 Jun 2024 | 1 | -$11,421 | 4 | Director | 18 Jun 2024, 18:11 |
| CGON | CG Oncology, Inc. | 24 Jan 2024 | 0 | $0 | 3 | Director | 24 Jan 2024, 20:56 |
| QURE | uniQure N.V. | 13 Jun 2023 | 3 | -$43,140 | 4 | Director | 20 Jun 2023, 17:28 |
| QURE | uniQure N.V. | 27 Feb 2023 | 1 | -$7,675 | 4 | Director | 01 Mar 2023, 15:19 |
| FLGT | Fulgent Genetics, Inc. | 01 Aug 2022 | 1 | $0 | 4 | Director | 03 Aug 2022, 17:44 |
| FLGT | Fulgent Genetics, Inc. | 01 Aug 2022 | 0 | $0 | 3 | Director | 03 Aug 2022, 17:34 |
| QURE | uniQure N.V. | 15 Jun 2022 | 2 | $0 | 4 | Director | 17 Jun 2022, 16:59 |
| QURE | uniQure N.V. | 28 Feb 2022 | 1 | -$13,229 | 4 | Director | 02 Mar 2022, 16:45 |
| QURE | uniQure N.V. | 24 Feb 2022 | 2 | $0 | 4 | Director | 28 Feb 2022, 17:43 |